Global dynamics for a model of amyloid fibril formation in pancreatic islet beta cells subjected to a therapy.

Journal of Biological Dynamics
Rodrigue Yves M'pika MassoukouNana Adjoah Mbroh

Abstract

Amyloid polypeptide (IAPP) fibril formation is the main cause of type II diabetes mellitus (T2DM) disease and cardiovascular disease (CVD). Therefore, implementing therapeutic interventions strategies to control IAPP fibril formation plays a crucial role in preventing and managing T2DM disease and CVD. For this purpose, in this paper, we make use of a mathematical model to investigate the effects of drug therapy on the dynamics of amyloid fibril formation (or amyloid plaques). The model is a hybrid system of differential equations consisting of ODEs and (hyperbolic) PDE. The (global) stability analysis is established through the construction of suitable Lyapunov functionals and application of Lasalle's invariance principle. Moreover, stability of the disease steady state is fully determined by a threshold condition, which is based on the total population of IAPP polymers.

References

Jul 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·P WestermarkC Betsholtz
Dec 28, 2002·Diabetes·Alexandra E ButlerPeter C Butler
Apr 30, 2003·Biophysical Journal·Elizabeth Rhoades, Ari Gafni
Aug 5, 2004·The Journal of Clinical Endocrinology and Metabolism·Rebecca L HullSteven E Kahn
Feb 7, 2006·The International Journal of Biochemistry & Cell Biology·Jo W M Höppener, Cees J M Lips
Mar 4, 2008·Endocrine Reviews·Leena HaatajaPeter C Butler
Jul 1, 2008·Journal of the American Society of Hypertension : JASH·Melvin R Hayden, James R Sowers

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.